1. Thermal analysis assisted by spectra-structure studies of BCS class II active pharmaceutical ingredients: ezetimibe and lercanidipine hydrochloride. The concept of preformulation.
- Author
-
Chachorovska, Marina, Petrushevski, Gjorgji, Stojanovska Pecova, Monika, Ugarkovic, Sonja, and Makreski, Petre
- Subjects
- *
THERMAL analysis , *DRUG solubility , *FOURIER transform infrared spectroscopy , *DIFFERENTIAL scanning calorimetry , *EZETIMIBE , *X-ray powder diffraction - Abstract
A detailed thermal analysis investigation of title BCS class II active pharmaceutical ingredients with low solubility and high permeability and known polymorphism were reported. Differential scanning calorimetry (DSC) and thermogravimetry analysis (TG) were used as primary screening techniques to assess into the polymorphic stability of the studied APIs relative to their thermal properties. The solid-state behavior of the drug compounds was further evaluated by X-ray powder diffraction (XRPD) and Fourier transform infrared spectroscopy (FT-IR). The spectra-structural techniques were applied as supportive tools to confirm and correlate the DSC and TG results obtained by preformulation testing. As an attempt to broaden the thermal analysis, a temperature-modulated DSC (TMDSC) was developed to examine the physical properties and explain the polymorphic stability of the studied amorphous lercanidipine HCl. The TMDSC results also aimed to determine the thermal properties comprising glass transition temperature (Tg) and heat capacity (ΔCp). Based on the thermal evolution and the applied preformulation tests, both drug substances manifested considerable increase in their moisture content (hygroscopicity) in relatively short time after exposure on elevated relative humidity in stability testing chambers. The results obtained from the above-mentioned instrumentation inevitably confirmed occurrence of polymorphic transition for both active substances after recrystallization from absolute ethanol. To the best of our knowledge, the study reports new type of crystalline form of lercanidipine HCl as well as unveils the transition of anhydrous ezetimibe to monohydrate form. In addition, the thermal behavior of amorphous lercanidipine HCl is, for the first time, outlined and described in this work. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF